Clinical Evaluation of the Safety and Efficacy of the Phytomedicine APIVIRINE Based on Aqueous Extracts of <i>Dichrostachys glomerata</i> (Forssk.). Chiov. (<i>D. cinerea</i>) in COVID-19 Patients without Signs of Severity — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
Clinical Evaluation of the Safety and Efficacy of the Phytomedicine APIVIRINE Based on Aqueous Extracts of <i>Dichrostachys glomerata</i> (Forssk.). Chiov. (<i>D. cinerea</i>) in COVID-19 Patients without Signs of Severity
Service de Pneumologie/Centre Hospitalier Universitaire Yalgado Ouédraogo (CHU-YO), Ouagadougou, Burkina Faso
,
Institut de Recherche en Sciences de la Santé/Centre National de la Recherche Scientifique et Technologique (IRSS/CNRST), Ouaga-dougou, Burkina Faso
,
Institut de Recherche en Sciences de la Santé/Centre National de la Recherche Scientifique et Technologique (IRSS/CNRST), Ouaga-dougou, Burkina Faso
,
Service de Pneumologie/Centre Hospitalier Universitaire Yalgado Ouédraogo (CHU-YO), Ouagadougou, Burkina Faso
,
Institut de Recherche en Sciences de la Santé/Centre National de la Recherche Scientifique et Technologique (IRSS/CNRST), Ouaga-dougou, Burkina Faso
,
Institut de Recherche en Sciences de la Santé/Centre National de la Recherche Scientifique et Technologique (IRSS/CNRST), Ouaga-dougou, Burkina Faso
,
Institut de Recherche en Sciences de la Santé/Centre National de la Recherche Scientifique et Technologique (IRSS/CNRST), Ouaga-dougou, Burkina Faso
,
Institut de Recherche en Sciences de la Santé/Centre National de la Recherche Scientifique et Technologique (IRSS/CNRST), Ouaga-dougou, Burkina Faso
,
Institut de Recherche en Sciences de la Santé/Centre National de la Recherche Scientifique et Technologique (IRSS/CNRST), Ouaga-dougou, Burkina Faso
,
Institut de Recherche en Sciences de la Santé/Centre National de la Recherche Scientifique et Technologique (IRSS/CNRST), Ouaga-dougou, Burkina Faso
,
Institut de Recherche en Sciences de la Santé/Centre National de la Recherche Scientifique et Technologique (IRSS/CNRST), Ouaga-dougou, Burkina Faso
,
Institut de Recherche en Sciences de la Santé/Centre National de la Recherche Scientifique et Technologique (IRSS/CNRST), Ouaga-dougou, Burkina Faso
,
Institut de Recherche en Sciences de la Santé/Centre National de la Recherche Scientifique et Technologique (IRSS/CNRST), Ouaga-dougou, Burkina Faso
1 Service de Pneumologie/Centre Hospitalier Universitaire Yalgado Ouédraogo (CHU-YO), Ouagadougou, Burkina Faso
2 Institut de Recherche en Sciences de la Santé/Centre National de la Recherche Scientifique et Technologique (IRSS/CNRST), Ouaga-dougou, Burkina Faso
3 Institut de Recherche en Sciences de la Santé/Centre National de la Recherche Scientifique et Technologique (IRSS/CNRST), Ouaga-dougou, Burkina Faso
4 Service de Pneumologie/Centre Hospitalier Universitaire Yalgado Ouédraogo (CHU-YO), Ouagadougou, Burkina Faso
5 Institut de Recherche en Sciences de la Santé/Centre National de la Recherche Scientifique et Technologique (IRSS/CNRST), Ouaga-dougou, Burkina Faso
6 Institut de Recherche en Sciences de la Santé/Centre National de la Recherche Scientifique et Technologique (IRSS/CNRST), Ouaga-dougou, Burkina Faso
7 Institut de Recherche en Sciences de la Santé/Centre National de la Recherche Scientifique et Technologique (IRSS/CNRST), Ouaga-dougou, Burkina Faso
8 Institut de Recherche en Sciences de la Santé/Centre National de la Recherche Scientifique et Technologique (IRSS/CNRST), Ouaga-dougou, Burkina Faso
9 Institut de Recherche en Sciences de la Santé/Centre National de la Recherche Scientifique et Technologique (IRSS/CNRST), Ouaga-dougou, Burkina Faso
10 Institut de Recherche en Sciences de la Santé/Centre National de la Recherche Scientifique et Technologique (IRSS/CNRST), Ouaga-dougou, Burkina Faso
11 Institut de Recherche en Sciences de la Santé/Centre National de la Recherche Scientifique et Technologique (IRSS/CNRST), Ouaga-dougou, Burkina Faso
12 Institut de Recherche en Sciences de la Santé/Centre National de la Recherche Scientifique et Technologique (IRSS/CNRST), Ouaga-dougou, Burkina Faso
13 Institut de Recherche en Sciences de la Santé/Centre National de la Recherche Scientifique et Technologique (IRSS/CNRST), Ouaga-dougou, Burkina Faso
Background: Since the appearance of the COVID-19 pandemic, several drugs have also been proposed for the treatment of the COVID-19, but the therapeutic effectiveness of those drugs is not satisfactory. This situation has led to the search for therapeutic solutions based on recipes from traditional medicine. Aims: This study aimed to evaluate the clinical safety, efficacy and tolerability of the phytomedicine APIVIRINE in patients with non-severe COVID-19. Methods: Patients were included following defined criteria and followed on an outpatient basis until recovery in accordance with national guidelines for the management of single cases of COVID-19 in Burkina Faso. Vital signs, anthropometric parameters as well as electrocardiographic, hematological and biochemical examinations were measured on D4, D7, D14 and D21. Adverse events were recorded during maintenance. Results: The present study included 45 patients. The clinical signs present at inclusion were mostly cough (44.44%), asthenia (42.22%), headache (40%), and anosmia (35.55%). Dyspnoea and chest pain were less represented in 05 (11.11%) and 06 (13.33%) patients. Cough, dyspnoea, chest pain, fever, sore throat, headache, and nasal obstruction present at inclusion disappeared before Day 4 of treatment. Anosmia and asthenia disappeared before Day 7. At the inclusion visit (Day 1), CRP, WBC, and blood glucose were abnormal in 15 (33.33%), 13 (28.89%), and 11 (24.44%) patients respectively. In addition, 3 (6.66%) patients had elevated creatinine levels. Transaminases Alanine aminotransferase (ALAT) were elevated in 05 (11.11%) patients while Aspartate aminotransferase (ASAT) was elevated in 04 (8.89%) patients. After 4 days of treatment, the cure rate was 33.33% of patients and 48.89% after 7 days. The cumulative cure rate was 86.67% after 14 days of treatment. Conclusion: No serious side effects or allergic reactions were observed during treatment. No clinical complications were observed and all symptoms present resolved on the 7th day of treatment.
KeywordsAPIVIRINECOVID-19Clinical StudySafety
Lone, S.A. and Ahmad, A. (2020) COVID-19 Pandemic—An African Perspective. Emerging Microbes & Infections, 9, 1300-1308. https://doi.org/10.1080/22221751.2020.1775132
Bonny, V., Maillard, A., Mousseaux, C., Plaçais, L. and Richier, Q. (2020) COVID-19: Physiopathologie d’une maladie à plusieurs visages. La Revue de Médecine Interne, 41, 375-389. https://doi.org/10.1016/j.revmed.2020.05.003
Rouamba, T., Barry, H., Ouédraogo, E., Tahita, M.C., Yaméogo, N.V., Poda, A., et al. (2021) Safety of Chloroquine or Hydroxychloroquine plus Azithromycin for the Treatment of COVID-19 Patients in Burkina Faso: An Observational Prospective Cohort Study. Therapeutics and Clinical Risk Management, 17, 1187-1198. https://doi.org/10.2147/TCRM.S330813
Zhang, X.-Y., Lv, L., Zhou, Y.-L., Xie, L.-D., Xu, Q., Zou, X.-F., et al. (2021) Efficacy and Safety of Xiyanping Injection in the Treatment of COVID-19: A Multicenter, Prospective, Open-Label and Randomized Controlled Trial. Phytotherapy Research, 35, 4401-4410. https://doi.org/10.1002/ptr.7141
Organisation Mondiale de la Santé. (2014) Médecine traditionnelle. Rapport du Secrétariat, Report No. A67/26. OMS, 6.
Organisation Mondiale de la Santé (2021) Médecine traditionnelle et complémentaire. Report No. WPR/RC72/6. OMS, Geneva, 6.
WHO (2020) WHO, Africa CDC Push for COVID-19 Traditional Medicine Research in Africa. https://www.who.int/news-room/feature-stories/detail/who-africa-cdc-push-for-covid-19-traditional-medicine-research-in-africa
Alam, S., Sarker, M.M.R., Afrin, S., Richi, F.T., Zhao, C., Zhou, J.-R., et al. (2021). Traditional Herbal Medicines, Bioactive Metabolites, and Plant Products against COVID-19: Update on Clinical Trials and Mechanism of Actions. Frontiers in Pharmacology, 12, Article 671498. https://doi.org/10.3389/fphar.2021.671498
Ren, W., Ma, Y., Wang, R., Liang, P., Sun, Q., Pu, Q., et al. (2021) Research Advance on Qingfei Paidu Decoction in Prescription Principle, Mechanism Analysis and Clinical Application. Frontiers in Pharmacology, 11, Article 589714. https://doi.org/10.3389/fphar.2020.589714
Shah, T., Shah, Z., Xia, K.-Y. and Baloch, Z. (2022) Therapeutic Mechanisms and Impact of Traditional Chinese Medicine on COVID-19 and Other Influenza Diseases. Pharmacological Research—Modern Chinese Medicine, 2, Article ID: 100029. https://doi.org/10.1016/j.prmcm.2021.100029
Wen, J., Wang, R., Liu, H., Tong, Y., Wei, S., Zhou, X., et al. (2020) Potential Therapeutic Effect of Qingwen Baidu Decoction against Corona Virus Disease 2019: A Mini Review. Chinese Medicine, 15, Article No. 48. https://doi.org/10.1186/s13020-020-00332-y
Abou Zeid, A.H., Hifnawy, M.S. and Mohammed, R.S. (2009) Phenolic Compounds and Biological Activities of Dichrostachys cinerea L. Medicinal and Aromatic Plant Science and Biotechnology, 3, 42-49.
Vijayalakshmi, M., Periyanayagam, K. and Lakshmana, P.S. (2010) Invitro Antilice Activity of Dichrostachys cinerea (L.) Wight & Arn. International Journal of PharmTech Research, 2, 2210-2213.
Neondo, J.O., Mbithe, C.M., Njenga, P.K. and Muthuri, C.W. (2012) Phytochemical Characterization, Antibacterial Screening and Toxicity Evaluation of Dichrostachys Cinerea. International Journal of Medicinal Plants Research, 1, 32-37.
El-Sharawy, R.T., Elkhateeb, A., Marzouk, M.M., Abd El-Latif, R.R., Abdelrazig, S.E. and El-Ansari, M.A. (2017) Antiviral and Antiparasitic Activities of Clovamide: The Major Constituent of Dichrostachys cinerea (L.) Wight et Arn. Journal of Applied Pharmaceutical Science, 7, 219-223.
Agrawal, P.K., Agrawal, C. and Blunden, G. (2020) Quercetin: Antiviral Significance and Possible COVID-19 Integrative Considerations. Natural Product Communications, 15, Article ID: 1934578X2097629. https://doi.org/10.1177/1934578X20976293
Al-Shuhaib, M.B.S., Hashim, H.O. and Al-Shuhaib, J.M.B.(2022) Epicatechin Is a Promising Novel Inhibitor of SARS-CoV-2 Entry by Disrupting Interactions Between Angiotensin-Converting Enzyme Type 2 and the Viral Receptor Binding Domain: A Computational/Simulation Study. Computers in Biology and Medicine, 141, Article ID: 105155. https://doi.org/10.1016/j.compbiomed.2021.105155
Diniz, L.R.L., Elshabrawy, H.A., de Santana Souza, M.T., Duarte, A.B.S., Datta, S. and de Sousa, D.P. (2021) Catechins: Therapeutic Perspectives in COVID-19-Associated Acute Kidney Injury. Molecules, 26, Article No. 5951. https://doi.org/10.3390/molecules26195951
Liskova, A., Samec, M., Koklesova, L., Samuel, S.M., Zhai, K., Al-Ishaq, R.K., et al. (2021) Flavonoids against the SARS-CoV-2 Induced Inflammatory Storm. Biomedicine & Pharmacotherapy, 138, Article ID: 111430. https://doi.org/10.1016/j.biopha.2021.111430
Cohen, J. (1988) Statistical Power Analysis for the Behavioral Sciences. 2nd Edition, Erlbaum Associates, Hillsdale.
Meo, S.A., Klonoff, D.C. and Akram, J. (2020) Efficacy of Chloroquine and Hydroxychloroquine in the Treatment of COVID-19. European Review for Medical and Pharmacological Sciences, 24, 4539-4547.
Deeks, J.J., Dinnes, J., Takwoingi, Y., Davenport, C., Spijker, R., Taylor-Phillips, S., et al. (2020) Antibody Tests for Identification of Current and Past Infection with SARS-CoV-2. Cochrane Database of Systematic Reviews, No. 6, Article No. CD013652. https://doi.org/10.1002/14651858.CD013652
Liang, S.-B., Zhang, Y.-Y., Shen, C., Liang, C.-H., Lai, B.-Y., Dai, N., et al. (2021) Chinese Herbal Medicine Used with or without Conventional Western Therapy for COVID-19: An Evidence Review of Clinical Studies. Frontiers in Pharmacology, 11, Article 583450. https://doi.org/10.3389/fphar.2020.583450
Rabier, V., Dubée, V., Abgueguen, P., Mahieux, R., Delbos, V., Fialaire, P., et al. (2020) Réévaluation à distance de la symptomatologie des patients atteints de forme légère à modérée de COVID-19. Médecine et Maladies Infectieuses, 50, S79. https://doi.org/10.1016/j.medmal.2020.06.156
Babu, P.S., Krishna, V., Maruthi, K., Shankarmurthy, K. and Babu, R. (2011) E Evaluation of Acute Toxicity and Hepatoprotective Activity of the Methanolic Extract of Dichrostachys Cinerea (Wight and Arn.) Leaves. Pharmacognosy Research, 3, 40-43. https://doi.org/10.4103/0974-8490.79114
Kothari, S.C., Shivarudraiah, P., Venkataramaiah, S.B., Gavara, S., Arumugam, S.N. and Soni, M.G. (2014) Toxicologic Evaluation of Dichrostachys glomerata Extract: Subchronic Study in Rats and Genotoxicity Tests. Food and Chemical Toxicology, 69, 120-131. https://doi.org/10.1016/j.fct.2014.03.045
Kullar, R., Patel, A.P. and Saab, S. (2020) Hepatic Injury in Patients with COVID-19. Journal of Clinical Gastroenterology, 54, 841-849. https://doi.org/10.1097/MCG.0000000000001432
Guan, W., Ni, Z., Hu, Y., Liang, W., Ou, C., He, J., et al. (2020) Clinical Characteristics of Coronavirus Disease 2019 in China. New England Journal of Medicine, 382, 1708-1720. https://doi.org/10.1056/NEJMoa2002032
Wang, Y., Liu, Y., Liu, L., Wang, X., Luo, N. and Li, L. (2020) Clinical Outcomes in 55 Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Who Were Asymptomatic at Hospital Admission in Shenzhen, China. The Journal of Infectious Diseases, 221, 1770-1774. https://doi.org/10.1093/infdis/jiaa119
Bénézit, F., Armange, L., Picard, L., Paz, D.L., Pronier, C., Patrat-Delon, S., et al. (2020) Histoire naturelle de la COVID-19 avec suivi prospectif systématique standardisé: Combien de temps durent les symptômes? Médecine et Maladies Infectieuses, 50, S79. https://doi.org/10.1016/j.medmal.2020.06.157
Liu, B., Jayasundara, D., Pye, V., Dobbins, T., Dore, G.J., Matthews, G., et al. (2021) Whole of Population-Based Cohort Study of Recovery Time from COVID-19 in New South Wales Australia. The Lancet Regional Health—Western Pacific, 12, Article ID: 100193. https://doi.org/10.1016/j.lanwpc.2021.100193
Abou Zeid, A.H., Hifnawy, M.S., Mohammed, R.S. and Sleem, A.A. (2015) Lipoidal Contents, Analgesic and Antipyretic Activities of the Aerial Parts of Dichrostachys cinerea L. Journal of Herbs, Spices & Medicinal Plants, 21, 118-128. https://doi.org/10.1080/10496475.2014.920459
Irié-N’guessan, G., et al. (2011) Tracheal Relaxation of Five Ivorian Anti-Asthmatic Plants: Role of Epithelium and K+ Channels in the Effect of the Aqueous-Alcoholic Extract of Dichrostachys cinerea Root Bark. Journal of Ethnopharmacology, 138, 432-438. https://doi.org/10.1016/j.jep.2011.09.016
Kuate, D., Etoundi, B.C., Ngondi, J.L., Muda, W. and Oben, J.E. (2013) Anti-Inflammatory, Anthropometric and Lipomodulatory Effects Dyglomera® (Aqueous Extract of Dichrostachys glomerata) in Obese Patients with Metabolic Syndrome. Functional Foods in Health and Disease, 3, 416-427. https://doi.org/10.31989/ffhd.v3i11.35
Cao, B., Wang, Y., Wen, D., Liu, W., Wang, J., Fan, G., et al. (2020) A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. New England Journal of Medicine, 382, 1787-99. https://doi.org/10.1056/NEJMoa2001282
Wang, Y., Lu, C., Li, H., Qi, W., Ruan, L., Bian, Y., et al. (2021) Efficacy and Safety Assessment of Severe COVID-19 Patients with Chinese Medicine: A Retrospective Case Series Study at Early Stage of the COVID-19 Epidemic in Wuhan, China. Journal of Ethnopharmacology, 277, Article ID: 113888. https://doi.org/10.1016/j.jep.2021.113888
Kudi, A.C. and Myint, S.H. (1999) Antiviral Activity of Some Nigerian Medicinal Plant Extracts. Journal of Ethnopharmacology, 68, 289-294. https://doi.org/10.1016/S0378-8741(99)00049-5
Khazdair, M.R., Anaeigoudari, A. and Agbor, G.A. (2021) Anti-Viral and Anti-Inflammatory Effects of Kaempferol and Quercetin and COVID-2019: A Scoping Review. Asian Pacific Journal of Tropical Biomedicine, 11, 327-334. https://doi.org/10.4103/2221-1691.319567
Farhat, A., Ben Hlima, H., Khemakhem, B., Ben Halima, Y., Michaud, P., Abdelkafi, S., et al. (2022) Apigenin Analogues as SARS-CoV-2 Main Protease Inhibitors: In-Silico Screening Approach. Bioengineered, 13, 3350-3361. https://doi.org/10.1080/21655979.2022.2027181